• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗原特异性抗体 Fc 糖基化通过募集补体增强体液免疫。

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.

机构信息

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

Department of Immunology and Biotechnology, Tropical Medicine Research Institute, Khartoum, Sudan.

出版信息

Sci Immunol. 2018 Aug 17;3(26). doi: 10.1126/sciimmunol.aat7796.

DOI:10.1126/sciimmunol.aat7796
PMID:30120121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6298214/
Abstract

HIV-specific broadly neutralizing antibodies (bNAbs) confer protection after passive immunization, but the immunological mechanisms that drive their development are poorly understood. Structural features of bNAbs indicate that they originate from extensive germinal center (GC) selection, which relies on persistent GC activity. However, why a fraction of infected individuals are able to successfully drive more effective affinity maturation is unclear. Delivery of antigens in the form of antibody-immune complexes (ICs), which bind to complement receptors (CRs) or Fc receptors (FcRs) on follicular dendritic cells, represents an effective mechanism for antigen delivery to the GC. We sought to define whether IC-FcR or CR interactions differ among individuals who develop bNAb responses to HIV. Enhanced Fc effector functions and FcR/CR interactions, via altered Fc glycosylation profiles, were observed among individuals with neutralizing antibody responses to HIV compared with those without neutralizing antibody activity. Moreover, both polyclonal neutralizer ICs and monoclonal IC mimics of neutralizer antibodies induced higher antibody titers, higher-avidity antibodies, and expanded GC B cell reactions after immunization of mice via accelerated antigen deposition within B cell follicles in a complement-dependent manner. Thus, these data point to a direct role for altered Fc profile/complement interactions in shaping the maturation of the humoral immune response, providing insights into how GC activity may be enhanced to drive affinity maturation in next-generation vaccine approaches.

摘要

HIV 特异性广泛中和抗体(bNAb)在被动免疫后提供保护,但驱动其产生的免疫机制仍知之甚少。bNAb 的结构特征表明,它们源自广泛的生发中心(GC)选择,这依赖于持续的 GC 活性。然而,为什么一部分感染者能够成功地驱动更有效的亲和力成熟尚不清楚。以抗体免疫复合物(IC)的形式递呈抗原,这些复合物结合滤泡树突状细胞上的补体受体(CR)或 Fc 受体(FcR),代表了将抗原递呈给 GC 的有效机制。我们试图确定在产生 HIV bNAb 反应的个体中,IC-FcR 或 CR 相互作用是否存在差异。与没有中和抗体活性的个体相比,对 HIV 产生中和抗体反应的个体中观察到增强的 Fc 效应子功能和 FcR/CR 相互作用,这是通过改变 Fc 糖基化谱实现的。此外,多克隆中和性 IC 以及中和性抗体的单克隆 IC 模拟物在通过补体依赖性方式加速 B 细胞滤泡内的抗原沉积来免疫小鼠后,诱导更高的抗体滴度、更高亲和力的抗体和扩大 GC B 细胞反应。因此,这些数据表明,改变的 Fc 谱/补体相互作用在塑造体液免疫反应的成熟中具有直接作用,为了解 GC 活性如何增强以驱动下一代疫苗方法中的亲和力成熟提供了线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/139688bba977/SI-03-eaat7796-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/618689d2ebea/SI-03-eaat7796-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/be22748850f5/SI-03-eaat7796-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/72018b1a877a/SI-03-eaat7796-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/ef03c24e8999/SI-03-eaat7796-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/139688bba977/SI-03-eaat7796-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/618689d2ebea/SI-03-eaat7796-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/be22748850f5/SI-03-eaat7796-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/72018b1a877a/SI-03-eaat7796-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/ef03c24e8999/SI-03-eaat7796-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/682d/6516197/139688bba977/SI-03-eaat7796-g005.jpg

相似文献

1
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.抗原特异性抗体 Fc 糖基化通过募集补体增强体液免疫。
Sci Immunol. 2018 Aug 17;3(26). doi: 10.1126/sciimmunol.aat7796.
2
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.一种人巨细胞病毒预融合样糖蛋白B亚基疫苗在小鼠中引发的体液免疫与融合后gB相似。
J Virol. 2025 Jun 17;99(6):e0217824. doi: 10.1128/jvi.02178-24. Epub 2025 May 8.
3
Interactions Between the Innate and Adaptive Immune Responses.先天性免疫反应与适应性免疫反应之间的相互作用
Adv Exp Med Biol. 2025;1476:297-308. doi: 10.1007/978-3-031-85340-1_12.
4
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.地方性冠状病毒感染与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Fc受体结合抗体有关。
J Virol. 2025 Jun 17;99(6):e0055025. doi: 10.1128/jvi.00550-25. Epub 2025 May 19.
5
An engineered antibody-lectin conjugate targeting the HIV glycan shield protects humanized mice against HIV challenge.一种靶向HIV聚糖屏蔽层的工程化抗体-凝集素缀合物可保护人源化小鼠免受HIV攻击。
Mol Ther. 2025 Jul 2;33(7):3147-3162. doi: 10.1016/j.ymthe.2025.03.039. Epub 2025 Mar 27.
6
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.多抗原修饰的安卡拉痘苗病毒疫苗载体在小鼠体内诱导针对人巨细胞病毒的体液和细胞免疫应答。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01012-18. Print 2018 Oct 1.
7
Vaccine-Induced Anti-IgE Antibodies Neutralize Free IgE but Fail to Bind and Activate Mast Cell-Displayed IgE.疫苗诱导的抗IgE抗体可中和游离IgE,但无法结合并激活肥大细胞表面展示的IgE。
Allergy. 2025 Jul;80(7):1995-2007. doi: 10.1111/all.16530. Epub 2025 Apr 7.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection.在感染 HIV 的儿童中,独特的免疫球蛋白 Fc 糖基化模式与疾病无进展和广泛中和抗体反应相关。
mSphere. 2020 Dec 23;5(6):e00880-20. doi: 10.1128/mSphere.00880-20.
10
Sexual Harassment and Prevention Training性骚扰与预防培训

引用本文的文献

1
Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates.免疫接种的多样性对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体功能替代指标有强烈影响。
NPJ Vaccines. 2025 Jul 29;10(1):175. doi: 10.1038/s41541-025-01226-6.
2
A multivalent binding model infers antibody Fc species from systems serology.一种多价结合模型可从系统血清学推断抗体Fc种类。
PLoS Comput Biol. 2024 Dec 23;20(12):e1012663. doi: 10.1371/journal.pcbi.1012663. eCollection 2024 Dec.
3
Human IgG Subclasses Differ in the Structural Elements of Their -Glycosylation.

本文引用的文献

1
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.在感染早期,HIV 特异性 Fc 效应功能可预测广泛中和抗体的产生。
PLoS Pathog. 2018 Apr 9;14(4):e1006987. doi: 10.1371/journal.ppat.1006987. eCollection 2018 Apr.
2
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.佐剂对非人灵长类动物中HIV包膜反应的强度、质量和持久性的先天性转录影响。
Blood Adv. 2017 Nov 17;1(25):2329-2342. doi: 10.1182/bloodadvances.2017011411. eCollection 2017 Nov 28.
3
Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies.
人IgG亚类在其O-糖基化的结构元件上存在差异。
ACS Cent Sci. 2024 Oct 10;10(11):2048-2058. doi: 10.1021/acscentsci.4c01157. eCollection 2024 Nov 27.
4
Antibody-mediated control mechanisms of viral infections.病毒感染的抗体介导控制机制。
Immunol Rev. 2024 Nov;328(1):205-220. doi: 10.1111/imr.13383. Epub 2024 Aug 20.
5
A Fluorinated Sialic Acid Vaccine Lead Against Meningitis B and C.一种针对 B 型和 C 型脑膜炎的氟化唾液酸疫苗先导物。
J Am Chem Soc. 2024 Jun 5;146(22):15366-15375. doi: 10.1021/jacs.4c03179. Epub 2024 May 20.
6
Tethering of soluble immune effectors to mucin and chitin reflects a convergent and dynamic role in gut immunity.可溶性免疫效应分子与粘蛋白和几丁质的连接反映了在肠道免疫中具有趋同和动态的作用。
Philos Trans R Soc Lond B Biol Sci. 2024 May 6;379(1901):20230078. doi: 10.1098/rstb.2023.0078. Epub 2024 Mar 18.
7
Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon.补体系统直接增强病毒中和抗体效力:一个被广泛遗忘的现象。
Cell Mol Life Sci. 2024 Jan 11;81(1):22. doi: 10.1007/s00018-023-05074-2.
8
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function.高效抗委内瑞拉马脑炎病毒抗体的治疗效果取决于 Fc 效应功能。
MAbs. 2024 Jan-Dec;16(1):2297451. doi: 10.1080/19420862.2023.2297451. Epub 2024 Jan 3.
9
Understanding Fc function for rational vaccine design against pathogens.理解 Fc 功能,有助于针对病原体进行合理的疫苗设计。
mBio. 2024 Jan 16;15(1):e0303623. doi: 10.1128/mbio.03036-23. Epub 2023 Dec 19.
10
Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.活疫苗和灭活疫苗接种后诱导了不同的功能性体液免疫应答。
J Immunol. 2024 Jan 1;212(1):24-34. doi: 10.4049/jimmunol.2200956.
产生广泛中和抗体的HIV-1感染者的免疫扰动。
Sci Immunol. 2016 Jul 29;1(1):aag0851. doi: 10.1126/sciimmunol.aag0851.
4
Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies.突破外周耐受可促进HIV-1中和抗体的产生。
J Exp Med. 2017 Aug 7;214(8):2283-2302. doi: 10.1084/jem.20161190. Epub 2017 Jul 11.
5
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.使用优化方法通过HIV包膜三聚体免疫在非人灵长类动物中引发强大的二级中和抗体反应。
Immunity. 2017 Jun 20;46(6):1073-1088.e6. doi: 10.1016/j.immuni.2017.05.007.
6
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.用于评估抗原特异性抗体效应子谱的多重Fc阵列。
J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3.
7
Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV.病毒驱动的炎症与HIV自发控制者体内广谱中和抗体的产生有关。
Clin Infect Dis. 2017 Apr 15;64(8):1098-1104. doi: 10.1093/cid/cix057.
8
Native-like Env trimers as a platform for HIV-1 vaccine design.类天然Env三聚体作为HIV-1疫苗设计的平台。
Immunol Rev. 2017 Jan;275(1):161-182. doi: 10.1111/imr.12481.
9
Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.产生广泛中和抗体的HIV感染者的免疫特征。
Immunol Rev. 2017 Jan;275(1):62-78. doi: 10.1111/imr.12504.
10
New insights into the immunopathogenesis of systemic lupus erythematosus.系统性红斑狼疮发病机制的新见解。
Nat Rev Rheumatol. 2016 Nov 22;12(12):716-730. doi: 10.1038/nrrheum.2016.186.